Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Douglas A. Treco currently holds 13,000 shares of Inozyme Pharma, Inc. (INZY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Douglas A. Treco has been a net buyer of INZY stock. They have purchased $1.1M and sold $52.2K worth of shares.
Douglas A. Treco's most recent insider trade was on Jun 5, 2026, when they sold 13,000 shares at $0.00 per share.
Douglas A. Treco serves as Executive at Inozyme Pharma, Inc. (INZY). They have executed 11 insider transactions totaling $1.2M over their tenure at the company.
Douglas A. Treco holds the position of Executive at Inozyme Pharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Douglas A. Treco has shown a buying trading pattern, with $1.1M in total purchases and $52.2K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Douglas A. Treco was on Apr 2, 2020, when they sold $11.3M worth of RARX shares. This transaction involved 234,707 shares at $48.00 per share.
Douglas A. Treco currently owns 13,000 shares of Inozyme Pharma, Inc. (INZY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Douglas A. Treco's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Douglas A. Treco has 11 Form 4 filings on record as an insider at Inozyme Pharma, Inc..
Set alerts for Douglas A. Treco and 40,000+ other insiders.